• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普拉德-威利综合征:从遗传学到行为学,特别关注食欲治疗。

Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.

机构信息

Centre for Chronic Disease Prevention and Management, College of Health and Biomedicine, Victoria University, St. Albans Campus, 3021, Australia.

Centre for Chronic Disease Prevention and Management, College of Health and Biomedicine, Victoria University, St. Albans Campus, 3021, Australia.

出版信息

Neurosci Biobehav Rev. 2015 Dec;59:155-72. doi: 10.1016/j.neubiorev.2015.10.003. Epub 2015 Oct 22.

DOI:10.1016/j.neubiorev.2015.10.003
PMID:26475993
Abstract

Prader-Willi syndrome (PWS) is a neurodevelopmental disorder resulting from a deletion in the expression of the paternally derived alleles in the region of 15q11-q13. PWS has a prevalence rate of 1:10,000-1:30,000 and is characterized by marked endocrine abnormalities including growth hormone deficiency and raised ghrelin levels. The hyperphagic phenotype in PWS is established over a number of phases and is exacerbated by impaired satiety, low energy expenditure and intellectual difficulties including obsessive-compulsive disorder and/or autistic behaviours. Clinical management in PWS typically includes familial/carer restriction and close supervision of food intake. If the supervision of food is left unmanaged, morbid obesity eventuates, central to the risk of cardiorespiratory disorder. None of the current appetite management/intervention strategies for PWS include pharmacological treatment, though recent research shows some promise. We review the established aberrant genetics and the endocrine and neuronal attributes which may determine disturbed regulatory processes in PWS. Focusing on clinical trials for appetite behaviours in PWS, we define the effectiveness of pharmacological treatments with a view to initiating and focusing research towards possible targets for modulating appetite in PWS.

摘要

普拉德-威利综合征(PWS)是一种神经发育障碍,由 15q11-q13 区域父源等位基因表达缺失引起。PWS 的患病率为 1:10000-1:30000,其特征为明显的内分泌异常,包括生长激素缺乏和胃饥饿素水平升高。PWS 的暴食表型经过多个阶段发展,并因饱腹感受损、低能量消耗和智力困难(包括强迫症和/或自闭症行为)而加剧。PWS 的临床管理通常包括家庭/照顾者限制和密切监督食物摄入。如果不管理食物摄入,就会导致病态肥胖,这是心血管疾病风险的关键。目前用于治疗 PWS 的食欲管理/干预策略都不包括药物治疗,尽管最近的研究显示出一些希望。我们回顾了已确定的异常遗传学以及内分泌和神经元特征,这些特征可能决定了 PWS 中调节过程的紊乱。我们关注 PWS 中食欲行为的临床试验,以确定药物治疗的有效性,以期为调节 PWS 中的食欲确定可能的靶点,并开展相关研究。

相似文献

1
Prader-Willi syndrome: From genetics to behaviour, with special focus on appetite treatments.普拉德-威利综合征:从遗传学到行为学,特别关注食欲治疗。
Neurosci Biobehav Rev. 2015 Dec;59:155-72. doi: 10.1016/j.neubiorev.2015.10.003. Epub 2015 Oct 22.
2
Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome.食欲激素与 Prader-Willi 综合征患儿暴食的转变。
Int J Obes (Lond). 2012 Dec;36(12):1564-70. doi: 10.1038/ijo.2011.274. Epub 2012 Jan 24.
3
Effects of a single dose of exenatide on appetite, gut hormones, and glucose homeostasis in adults with Prader-Willi syndrome.艾塞那肽单次给药对 Prader-Willi 综合征成人的食欲、肠道激素和葡萄糖稳态的影响。
J Clin Endocrinol Metab. 2011 Aug;96(8):E1314-9. doi: 10.1210/jc.2011-0038. Epub 2011 Jun 1.
4
Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.成人普拉德-威利综合征的内分泌和代谢方面,特别强调生长激素治疗的效果。
Growth Horm IGF Res. 2004 Feb;14(1):1-15. doi: 10.1016/j.ghir.2003.09.003.
5
Mechanisms of obesity in Prader-Willi syndrome.普拉德-威利综合征的肥胖机制。
Pediatr Obes. 2018 Jan;13(1):3-13. doi: 10.1111/ijpo.12177. Epub 2016 Nov 10.
6
Prader-Willi Syndrome普拉德-威利综合征
7
Prader-Willi syndrome as a model of human hyperphagia.普拉德-威利综合征作为人类食欲亢进的模型。
Front Horm Res. 2014;42:93-106. doi: 10.1159/000358317. Epub 2014 Apr 7.
8
Prader- Willi syndrome: An uptodate on endocrine and metabolic complications.普拉德-威利综合征:内分泌和代谢并发症的最新进展。
Rev Endocr Metab Disord. 2019 Jun;20(2):239-250. doi: 10.1007/s11154-019-09502-2.
9
Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches.普拉德-威利综合征中的肥胖:病理生理学机制、营养和药理学方法。
J Endocrinol Invest. 2021 Oct;44(10):2057-2070. doi: 10.1007/s40618-021-01574-9. Epub 2021 Apr 23.
10
Hypothalamic neuropeptides and neurocircuitries in Prader Willi syndrome.下丘脑神经肽和普拉德威利综合征的神经回路。
J Neuroendocrinol. 2021 Jul;33(7):e12994. doi: 10.1111/jne.12994. Epub 2021 Jun 22.

引用本文的文献

1
Analysis of the Diet Quality and Nutritional State of Children, Youth, and Young Adults with Prader-Willi Syndrome: A Polish Multiple Case Study.普拉德-威利综合征儿童、青少年和青年的饮食质量和营养状况分析:波兰多案例研究。
Nutrients. 2023 Aug 31;15(17):3811. doi: 10.3390/nu15173811.
2
Liraglutide for Weight Management in Children and Adolescents With Prader-Willi Syndrome and Obesity.利拉鲁肽用于治疗伴有肥胖的 Prader-Willi 综合征儿童和青少年的体重管理。
J Clin Endocrinol Metab. 2022 Dec 17;108(1):4-12. doi: 10.1210/clinem/dgac549.
3
Linking oxytocin and arginine vasopressin signaling abnormalities to social behavior impairments in Prader-Willi syndrome.
将催产素和精氨酸加压素信号异常与 Prader-Willi 综合征的社交行为障碍联系起来。
Neurosci Biobehav Rev. 2022 Nov;142:104870. doi: 10.1016/j.neubiorev.2022.104870. Epub 2022 Sep 13.
4
Experiencing illness as a crisis by the caregivers of individuals with Prader-Willi Syndrome.照顾普拉德-威利综合征患者的人将其患病视为危机。
PLoS One. 2022 Sep 1;17(9):e0273295. doi: 10.1371/journal.pone.0273295. eCollection 2022.
5
Proteins and proteases of Prader-Willi syndrome: a comprehensive review and perspectives.普拉德-威利综合征的蛋白和蛋白酶:全面综述与展望。
Biosci Rep. 2022 Jun 30;42(6). doi: 10.1042/BSR20220610.
6
Prader-Willi Syndrome: Possibilities of Weight Gain Prevention and Treatment.普拉德-威利综合征:预防和治疗体重增加的可能性。
Nutrients. 2022 May 6;14(9):1950. doi: 10.3390/nu14091950.
7
Prader-Willi syndrome: an update on obesity and endocrine problems.普拉德-威利综合征:肥胖与内分泌问题的最新进展
Ann Pediatr Endocrinol Metab. 2021 Dec;26(4):227-236. doi: 10.6065/apem.2142164.082. Epub 2021 Dec 31.
8
Measuring Meaningful Benefit-Risk Tradeoffs to Promote Patient-Focused Drug Development in Prader-Willi Syndrome: A Discrete-Choice Experiment.衡量有意义的获益-风险权衡以促进普拉德-威利综合征以患者为中心的药物开发:一项离散选择实验
MDM Policy Pract. 2021 Sep 2;6(2):23814683211039457. doi: 10.1177/23814683211039457. eCollection 2021 Jul-Dec.
9
Visual food cue processing in children with Prader-Willi Syndrome.普拉德-威利综合征儿童的视觉食物线索加工。
Physiol Behav. 2021 Sep 1;238:113492. doi: 10.1016/j.physbeh.2021.113492. Epub 2021 Jun 8.
10
Appetite- and weight-inducing and -inhibiting neuroendocrine factors in Prader-Willi syndrome, Bardet-Biedl syndrome and craniopharyngioma versus anorexia nervosa.普拉德-威利综合征、巴德-比德尔综合征和颅咽管瘤与神经性厌食症中影响食欲和体重的神经内分泌诱导及抑制因子
Endocr Connect. 2021 May 19;10(5):R175-R188. doi: 10.1530/EC-21-0111.